Medical Spending To Treat Hyperlipidemia Up 350% 1996-2003, USA

Main Category: Cholesterol
Also Included In: Statins;  Cardiovascular / Cardiology;  Obesity / Weight Loss / Fitness
Article Date: 14 Feb 2006 - 20:00 PST

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:4 stars

4 (2 votes)

Healthcare Prof:3 stars

3 (2 votes)


Medical spending to treat hyperlipidemia, a group of conditions that includes high cholesterol and other lipid disorders, increased 350 percent from $4 billion in 1996 to a total of $18 billion in 2003, according to HHS' Agency for Healthcare Research and Quality.

Estimates from AHRQ's Medical Expenditure Panel Survey also show that the number of Americans who were reported to have expenditures to treat hyperlipidemia nearly tripled -- from 7.3 million in 1996 to 21.6 million in 2003. Private health insurers, government programs like Medicare and Medicaid, and patients paid for the health services used to treat hyperlipidemia, primarily prescribed medications and visits to doctor's offices and outpatient clinics.

Statins, one class of prescribed medications used to treat hyperlipidemia, accounted for about 90 percent of the drug expenditures to treat this condition in 2003.

From 1996 to 2003, the proportion of the Medicare population who used at least one statin during the year increased over 250 percent from 8.3 percent to 29.7 percent.

By 2003, the two top-selling drugs in the U.S. (ranked by expenditures) were statins. Total expenditures for Lipitor (Atorvastatin), the top-selling drug, were 7.8 billion, while expenditures for Zocor (Simvastatin) totaled 5.5 billion.

AHRQ data also indicate that, in terms of health care expenditures, heart disease and trauma were the most costly medical conditions in 2003.

MEPS collects information each year from a nationally representative sample of U.S. households about health care use, expenses, access, health status and quality. MEPS is a unique government survey because of the degree of detail in its data, as well as its ability to link data on health services spending and health insurance to demographic, employment, economic, health status, and other characteristics of individuals and families.

This AHRQ News and Numbers is based on online statistics found online in the MEPS Compendia of Tables. To access these data go to meps.ahrq.gov/CompendiumTables/TC_TOC.htm.

http://www.ahrq.gov

View drug information on Zocor.


Article adapted by Medical News Today from original press release.
Visit our cholesterol section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Christian Nordqvist. "Medical Spending To Treat Hyperlipidemia Up 350% 1996-2003, USA." Medical News Today. MediLexicon, Intl., 14 Feb. 2006. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/37751.php>

APA
Christian Nordqvist. (2006, February 14). "Medical Spending To Treat Hyperlipidemia Up 350% 1996-2003, USA." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/37751.php.

Please note: If no author information is provided, the source is cited instead.




Cholesterol

What Is Cholesterol?

Cholesterol is a fat (lipid) which is produced by the liver and is crucial for normal body functioning. Cholesterol exists in the outer layer of every cell in our body and has many functions. Read more...

Most Popular Articles



Follow Our Cholesterol News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Cholesterol Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »